Switching to risperidone after unsuccessful treatment of olanzapine in the first-episode schizophrenia: An open trial

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 6, 2006, Pages 1067-1072

  Takahashi, Hitoshi ^a   Yoshida, Keizo ^b   Ishigooka, Jun ^c   Higuchi, Hisashi ^d  

^a Yuri Kumiai General Hospital   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d Omagari City Hospital   (Japan)

Author keywords

First episode schizophrenia; Olanzapine; Open trial; Risperidone; Switching

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BIPERIDEN; BROTIZOLAM; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; FLUNITRAZEPAM; LAXATIVE; MAGNESIUM OXIDE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SENNOSIDE; TRIAZOLAM; TRIHEXYPHENIDYL;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGITATION; AKATHISIA; AMENORRHEA; ARTICLE; BLURRED VISION; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONSTIPATION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DYSKINESIA; DYSTONIA; EXCITEMENT; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEMALE; HUMAN; INSOMNIA; MALE; MUSCLE RIGIDITY; NAUSEA; PARKINSONISM; PRESCRIPTION; SCHIZOPHRENIA; SOMNOLENCE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; TREMOR; XEROSTOMIA;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DATA INTERPRETATION, STATISTICAL; DRUG THERAPY, COMBINATION; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 33746936666     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.03.041     Document Type: Article

References (22)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Press, Washington, DC
2. Bech P., Kastrup M., and Rafaelsen O.J. Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand Suppl 326 (1986) 1-37
3. Bobes J., Gibert J., Ciudad A., Alvarez E., Canas F., Carrasco J.L., et al. Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 473-481
4. Bradford D.W., Perkins D.O., and Lieberman J.A. Pharmacological management of first-episode schizophrenia and related nonaffective psychoses. Drugs 63 (2003) 2265-2283
5. Chouinard G., and Margolese H.C. Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophr Res 76 (2005) 247-265
6. Emsley R.A., and and the Risperidone Working Group. Risperidone in the treatment of first-episode psychotic patients: a double-blind multicentre study. Schizophr Bull 25 (1999) 721-729
7. Expert consensus panel for optimizing pharmacologic treatment of psychotic disorders. Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. J Clin Psychiatry 64 Suppl 12 (2003) 2-97
8. Gattaz W.F., Diehl A., Geuppert M.S., Hubrich P., Schmitt A., Linde I., et al. Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia: a randomized double-blind trial. Pharmacopsychiatry 37 (2004) 279-285
9. Knegtering R., Baselmans P., Castelein S., Bosker F., Bruggeman R., and van den Bosch R.J. Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels. Am J Psychiatry 162 (2005) 1010-1012
10. Kopala L., Good K.P., and Honer W.G. Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: response to low dose risperidone. J Clin Psychopharmacol 17 (1997) 308-313
11. Lambert M., Conus P., Schimmelmann B.G., Eide P., Ward J., Yuen H., et al. Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study. Pharmacopsychiatry 38 (2005) 206-213
12. Lieberman J.A., Tollefson G., Tohen M., Green A.I., Gur R.E., Kahn R., et al. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry 160 (2003) 1396-1404
13. Lindenmayer J.P., Bernstein-Hyman R., Grochowski S., and Bark N. Psychopathology of Schizophrenia: initial validation of a 5-factor model. Psychopathology 28 (1995) 22-31
14. Lindenmayer J.P., Volavka J., Lieberman J., Sheitman B., Citrome L., Chakos M., et al. Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial. J Clin Psychopharmacol 21 (2001) 448-453
15. Lindenmayer J.P., Czobor P., Volavka J., Lieberman J.A., Citrome L., Sheitman B., et al. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study. J Clin Psychiatry 63 (2002) 931-935
16. Malla A., and Payne J. First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophr Bull 31 (2005) 650-671
17. McGlashan T.H. A selective review of recent North American long-term follow up studies of schizophrenia. Schizophr Bull 14 (1988) 515-542
18. Melkersson K. Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients. J Clin Psychiatry 66 (2005) 761-767
19. Sanger T.M., Lieberman J.A., Tohen M., Grundy S., Beasley Jr. C., and Tollefson G.D. Olanzapine versus haloperidol treatment in first-episode psychosis. Am J Psychiatry 156 (1999) 79-87
20. Schulz S.C., Thomson R., and Brecher M. The efficacy of quetiapine vs haloperidol and placebo: a meta-analytic study of efficacy. Schizophr Res 62 (2003) 1-12
21. Volavka J., Czobor P., Sheitman B., Lindenmayer J.P., Citrome L., McEvoy J.P., et al. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry 159 (2002) 255-262
22. Waddington J.L., and Quinn J.F. From first to second generation antipsychotics. In: Ellenbroek B.A., and Cools A.R. (Eds). Atyipical antipsychotics (milestones in drug therapy) (2000), Birkhauser, Nijmegen 19-33